Biomedicare Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.37 M
as on 11-12-2024
- Revenue 7.82%
(FY 2022)
- Profit 54.88%
(FY 2022)
- Ebitda 10.88%
(FY 2022)
- Net Worth 6.39%
(FY 2022)
- Total Assets -7.06%
(FY 2022)
About Biomedicare Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.37 M.
Ranjit Singh and Poonam serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PTC132701
- Company No.
132701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biomedicare Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjit Singh  | Director | 24-Feb-2005 | Current |
| Poonam | Director | 18-Jul-2016 | Current |
Financial Performance of Biomedicare Laboratories.
Biomedicare Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.82% increase. The company also saw a substantial improvement in profitability, with a 54.88% increase in profit. The company's net worth moved up by a moderate rise of 6.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomedicare Laboratories?
In 2022, Biomedicare Laboratories had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Aug 2024 | ₹0.47 M | Open |
Hdfc Bank Limited Creation Date: 09 Mar 2023 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 12 Mar 2022 | ₹0.40 M | Open |
How Many Employees Work at Biomedicare Laboratories?
Unlock and access historical data on people associated with Biomedicare Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomedicare Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomedicare Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
